Czechia· CZ-0271032
EMOXEN PLUS
A naproxen and esomeprazole product containing naproxen + esomeprazole magnesium trihydrate, registered in Czechia by Bausch Health Ireland Limited, Dublin. The same ATC class is registered in 12 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Naproxen and esomeprazole is registered in 12 of 19 countries.
Countries holding a registration under ATC M01AE52 (naproxen and esomeprazole), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 7 of them publish a price we can compare per daily dose
Naproxen and esomeprazole · ATC M01AE52
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of naproxen and esomeprazole costs, country by country.
Normalised to the WHO defined daily dose (0.5 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Naproxen and esomeprazole · price per daily dose (0.5 g)
USD · FX 28 Sept 2026
- CH Switzerland$0.91
The record
At a glance
SÚKL (Czech Republic)- Active substance
- NAPROXEN + ESOMEPRAZOLE MAGNESIUM TRIHYDRATE
- Manufacturer
- Bausch Health Ireland Limited, Dublin
- Country
- Czechia (CZ)
- ATC code
- M01AE52
- ATC class
- Naproxen and esomeprazole
- Defined daily dose
- 0.5 g, O
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 1
1 priced- cz_kod_sukl027103230CZK 304.64
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
3 interactions on record for naproxen and esomeprazole.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Naproxen and esomeprazole · interactions on record
3 records
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Naproxen and esomeprazole in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandEmoxenBausch Health Ireland Ltd.
- United StatesNaproxen and esomeprazole magnesiumDr. Reddy's Laboratories Limited
- SwitzerlandNaproxen Esomeprazol Grünenthal 500 mg/20 mg, FilmtablettenGrünenthal Pharma AG
- IrelandNaproxen/Esomeprazole Abdi 500 mg/20 mg Modified Release TabletsAbdi Farma GmbH
- SpainEMOXEN 500 MG/20 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFGBausch Health Ireland Limited
- CanadaMYLAN-NAPROXEN/ESOMEPRAZOLE MRMYLAN PHARMACEUTICALS ULC
- FinlandEmoxenduoBausch Health Ireland Limited
- NorwayVamtexarSandoz A/S
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Naproxen/Esomeprazol 1a Pharma, Naproxen/Esomeprazol Sandoz
- Belgium · Vimovo
- Bulgaria · Вимово
- Germany · Naproxen/Esomeprazol Abdi, Vimovo
- Denmark · Emoxenduo
- Estonia · Esmapren, Naproxen/Esomeprazole Stada
- Spain · Emoxen, Naproxeno/Esomeprazol Cinfa
- Finland · Emoxenduo, Vamtexar
- United Kingdom (Northern Ireland) · Naproxen/Esomeprazole Msn Laboratories, Vimovo
- Croatia · Vamtexar, Xidofa
- Hungary · Apranax Plus
- Ireland · Naproxen / Esomeprazole Rowex, Naproxen/Esomeprazole Abdi
- Italy · Naprossene E Esomeprazolo Abdi, Vimovo
- Lithuania · Esmapren, Naproxen/Esomeprazole Stada
- Luxembourg · Vimovo
- Latvia · Esmapren, Naproxen/Esomeprazole Stada
- Netherlands · Vimovo
- Norway · Emoxenduo, Vamtexar
- Poland · Emoxen, Esonalgen
- Portugal · Naproxeno + Esomeprazol Sandoz, Vimovo
- Romania · Vimovo, Xidofa
- Sweden · Emoxenduo, Vimovo
- Slovenia · Combolly
- Slovakia · Emoxen Plus
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b1b4372b-d018-41e7-8ff4-8ba03b163d9c GET /v1/drugs/b1b4372b-d018-41e7-8ff4-8ba03b163d9c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "TBL MRL",
"source": "sukl",
"strength": "500MG/20MG",
"pack_size": "30",
"substance": "NAPROXEN + ESOMEPRAZOLE MAGNESIUM TRIHYDRATE",
"cz_kod_sukl": "0271032",
"product_type": "CH",
"substance_codes": "2453,16192",
"registration_state": "R",
"registration_number": "29/528/22-C"
}See everything about naproxen and esomeprazole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.